華西股份(000936.SZ):已收到無錫國聯首輪投資款約9.98億元
格隆匯 7 月 20日丨華西股份(000936.SZ)公佈,2020年7月13日,公司與無錫國聯產業投資有限公司(“無錫國聯”)、無錫致久企業管理合夥企業(有限合夥)(“無錫致久”)、一村資本有限公司(“一村資本”或“目標公司”)簽署完成《投資及合作協議》。根據協議約定,首輪投資無錫國聯將向華西股份受讓目標公司34.431%股權,交易價格約人民幣9.98億元。
根據《投資及合作協議》中關於首輪投資及首輪轉讓價款的支付等相關條款約定,公司已於2020年7月20日收到無錫國聯首輪投資款人民幣約9.98億元。據此,無錫國聯首輪投資已完成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.